Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epratuzumab + Rituximab in Low-Grade NHL
NCT00044902Phase 2Completed
- Sponsor
- Amgen
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of epratuzumab in non-Hodgkin lymphoma (NHL), sponsored by Amgen. Status: completed.
02
Drugs
epratuzumab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00044902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044902.